+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease



The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease



Acta Hepato-Gastroenterologica 22(5): 292-296



Determination of hepatic copper concentration is the most exact criterion in the diagnosis of Wilson's disease. In the course of penicillamine therapy the copper content in the liver decreases, but normal values are achieved only after five or more years of treatment. Normalisation of the hepatic cooper concentration lags distinctly behind the clinical state. Distinct improvement of clinical state is already reached after a half to one year of treatment. The correlation between hepatic copper concentration and the amount of copper's excreted in the urine is statistically significant before the starting of treatment and during administration of penicillamine as well. The urinary copper excretion is a good indirect and indicator of the copper concentration in the liver.

(PDF emailed within 1 workday: $29.90)

Accession: 027605517

Download citation: RISBibTeXText

PMID: 1199668


Related references

Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine. Die Medizinische Welt 32(3): 109-110, 1981

The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease. Materia Medica Polona. Polish Journal of Medicine and Pharmacy 8(1): 48-50, 1976

Changes in zinc metabolism during long-term D-penicillamine treatment of patients with Wilson-Konovalov disease. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(3): 356-359, 1984

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. Journal of Inherited Metabolic Disease 2018, 2018

Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. Journal of Inherited Metabolic Disease 2019, 2019

Wilson's disease (experience of long-term treatment with penicillamine---con penicilamina. Revista Clinica Espanola 133(5): 451-454, 1974

Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases. Deutsche Medizinische Wochenschrift 92(37): 1657-1662, 1967

Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine. Acta Neurologica. Quaderni 39: 160-164, 1979

Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate. Journal of Neurology 243(3): 269-273, 1996

Wilson's disease: long-term follow-up of a cohort of 24 patients treated with D-penicillamine. European Journal of Gastroenterology and Hepatology 22(5): 564-571, 2010

Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients. Frontiers in Molecular Neuroscience 10: 10, 2017

Long-term effects of a combination of D-penicillamine and zinc salts in the treatment of Wilson's disease in children. Experimental and Therapeutic Medicine 5(4): 1129-1132, 2013

Effects of long-term zinc treatment in Japanese patients with Wilson disease: efficacy, stability, and copper metabolism. Translational Research 156(6): 350-357, 2010

Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease. Journal of the European Academy of Dermatology and Venereology 29(2): 383-386, 2015

Menkes' disease: long-term treatment with copper and D-penicillamine. European Journal of Pediatrics 147(6): 621-625, 1988